Ixamib 4.0mg cap (Ixazomib Capsule) 4.0mg

Ixamib 4.0mg cap is a prescription medication containing Ixazomib, a proteasome inhibitor used in cancer treatment. This 4.0mg capsule is commonly prescribed for multiple myeloma management. Always consult a healthcare provider before use.

Strength

4.0mg

Manufacturer / TM Owner

Azista Bhutan Healthcare Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ixamib 4.0mg cap is primarily used to treat multiple myeloma, a type of blood cancer affecting plasma cells. It may be prescribed alongside other medications as part of a treatment regimen. Patients often ask, 'what is Ixamib 4.0mg used for' to understand its role in therapy.

Side Effects

This capsule works by slowing or stopping the growth of cancer cells in the body. Common effects include gastrointestinal changes and fatigue. Individual responses may vary based on treatment duration and health conditions.

Precautions & Warnings

Store Ixamib 4.0mg cap at room temperature, away from moisture and direct light. Keep out of reach of children and pets. Report any unusual symptoms to a healthcare provider promptly. Avoid handling if pregnant or breastfeeding.

Avoid Interactions

Ixamib 4.0mg cap may interact with other medications, including certain antibiotics and antifungals. Grapefruit products can affect how the drug is processed in the body. Always inform your doctor about all medications and supplements you are taking.

Frequently Asked Questions

Ixamib 4.0mg cap is used to treat multiple myeloma, a cancer of plasma cells.

Store at room temperature, away from moisture and direct light.

Consult your doctor before combining with other drugs to avoid interactions.

Common effects may include gastrointestinal changes and fatigue.

Consult a healthcare provider; it may not be safe for pregnant or breastfeeding individuals.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.